187 related articles for article (PubMed ID: 30183088)
21. Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection.
Baxter L; Gordon NS; Ott S; Wang J; Patel P; Goel A; Piechocki K; Silcock L; Sale C; Zeegers MP; Cheng KK; James ND; ; Bryan RT; Ward DG
Sci Rep; 2023 Jan; 13(1):1060. PubMed ID: 36658180
[TBL] [Abstract][Full Text] [Related]
22. A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.
Kavalieris L; O'Sullivan PJ; Suttie JM; Pownall BK; Gilling PJ; Chemasle C; Darling DG
BMC Urol; 2015 Mar; 15():23. PubMed ID: 25888331
[TBL] [Abstract][Full Text] [Related]
23. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer.
D Elia C; Pycha A; Folchini DM; Mian C; Hanspeter E; Schwienbacher C; Vjaters E; Pycha A; Trenti E
J Clin Pathol; 2019 Feb; 72(2):140-144. PubMed ID: 30355587
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis.
Eissa S; Habib H; Ali E; Kotb Y
Med Oncol; 2015 Jan; 32(1):413. PubMed ID: 25511320
[TBL] [Abstract][Full Text] [Related]
27. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
Pichler R; Fritz J; Tulchiner G; Klinglmair G; Soleiman A; Horninger W; Klocker H; Heidegger I
BJU Int; 2018 Jan; 121(1):29-37. PubMed ID: 28941000
[TBL] [Abstract][Full Text] [Related]
28. [Bladder cancer screening with urine-based tumour markers - occupational medical experience].
Nasterlack M; Feil G; Leng G; Pesch B; Huber S; Sievert KD; Johnen G; Taeger D; Mayer T; Kluckert M; Brüning T; Stenzl A
Aktuelle Urol; 2011 Mar; 42(2):128-34. PubMed ID: 21437837
[TBL] [Abstract][Full Text] [Related]
29. Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA.
Ward DG; Baxter L; Ott S; Gordon NS; Wang J; Patel P; Piechocki K; Silcock L; Sale C; Zeegers MP; Cheng KK; James ND; Bryan RT;
Eur Urol Oncol; 2023 Feb; 6(1):67-75. PubMed ID: 35410825
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
Wang J; Zhang X; Wang L; Dong Z; Du L; Yang Y; Guo Y; Wang C
J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233
[TBL] [Abstract][Full Text] [Related]
31. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
[TBL] [Abstract][Full Text] [Related]
32. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma.
Li G; Zhao A; Péoch M; Cottier M; Mottet N
Urol Oncol; 2017 May; 35(5):294-299. PubMed ID: 28089386
[TBL] [Abstract][Full Text] [Related]
33. Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?
Shirodkar SP; Lokeshwar VB
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1111-23. PubMed ID: 18588456
[TBL] [Abstract][Full Text] [Related]
34. Expression of microRNAs in the urine of patients with bladder cancer.
Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
36. MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.
Liu H; He W; Wang B; Xu K; Han J; Zheng J; Ren J; Shao L; Bo S; Lu S; Lin T; Huang J
BMC Cancer; 2018 Jun; 18(1):659. PubMed ID: 29907142
[TBL] [Abstract][Full Text] [Related]
37. Combined use of epithelial membrane antigen and nuclear matrix protein 52 as sensitive biomarkers for detection of bladder cancer.
Attallah AM; El-Far M; Abdallah SO; El-Waseef AM; Omran MM; Abdelrazek MA; Attallah AA; Saadh MJ; Radwan M; El-waffaey KA; Abol-Enei H
Int J Biol Markers; 2015 Nov; 30(4):e407-13. PubMed ID: 26349665
[TBL] [Abstract][Full Text] [Related]
38. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
[TBL] [Abstract][Full Text] [Related]
39. Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.
Tölle A; Blobel CC; Jung K
Biomark Med; 2018 Jun; 12(6):667-676. PubMed ID: 29896971
[TBL] [Abstract][Full Text] [Related]
40. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]